Form 10-Q · Quarterly report
Halliburton 10-Q, filed Oct 23, 2026
- Filed
- CIK
- 0000045012
- Accession no.
- 0000045012-26-000074
Summary
Halliburton reported third-quarter 2026 revenue of $5.7 billion, up 2% from a year earlier, and operating income of $624 million including $107 million in impairment and other pre-tax charges, in its quarterly report filed with the SEC. The company said it completed the sale of a portion of its chemical business in the second quarter of 2026 and that third-quarter oil prices fell from the prior quarter, with WTI averaging about $87 a barrel versus about $96.
Key points
- Completion and Production segment revenue fell 4% year over year, while Drilling and Evaluation revenue rose 10%.
- North America revenue decreased 9% year over year, and international revenue increased 9%.
- Halliburton repurchased 7.3 million shares in the third quarter, leaving about $1.5 billion authorized, and paid a quarterly dividend of $0.17 per share.
- The company reaffirmed 2026 capital spending of about $1.1 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion EXECUTIVE OVERVIEW Organization We are one of the world’s largest providers of products and services to the energy industry. We help our customers maximize asset value throughout the lifecycle of the reservoir from locating hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completion, and optimizing production throughout the life of the asset. Activity levels within our operations are significantly impacted by spending on upstream exploration, development, and production programs by major, national, and independent oil and natural gas companies. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.